Featured Research

from universities, journals, and other organizations

The case for maintaining current regulations on I-131 therapy

Date:
May 5, 2011
Source:
Society of Nuclear Medicine
Summary:
Two new articles make a case for maintaining current US Nuclear Regulatory Commission regulations on the release of patients who undergo radioactive iodine treatments for thyroid cancer, known as I-131.

Two articles in the June issue of The Journal of Nuclear Medicine make a case for maintaining current U.S. Nuclear Regulatory Commission (NRC) regulations on the release of patients who undergo radioactive iodine treatments for thyroid cancer. Currently, the NRC recommends outpatient treatment for patients receiving radioactive iodine after total or near-total thyroidectomy; however, several groups have been urging NRC to mandate overnight hospital stays to protect others from a perceived risk of radiation exposure.

Related Articles


The article, "Delayed Initial Radioactive Iodine Therapy Resulted in Poor Survival in Patients with Metastatic Differentiated Thyroid Carcinoma: A Retrospective Statistical Analysis of 198 Cases," evaluated the clinical factors that affected the survival of postoperative patients with differentiated thyroid cancer (DTC) in Japan. According to Tatsuya Higashi, MD, PhD, this is the first report that shows the prognostic value of early performance of radioactive iodine therapy.

Researchers found that the risk of death for patients who received radioactive iodine treatment more than 180 days after a total thyroidectomy was 4.22 times higher than for those treated within the initial 180 days. Several reasons were cited as causing delays in treatment time in Japan, including strict regulation of radioactive materials, a long waiting list for admission to the radioactive iodine therapy ward and delayed referral by the surgeons who performed the total thyroidectomy.

In a related article, "The Real Cost of Theoretic Risk Avoidance: The Need to Challenge Unsubstantiated Concerns About 131I Therapy," Stanley J. Goldsmith, MD, cites the Japan study as a reason to maintain current NRC regulations. If the NRC were to require overnight stays, he reasons, a backlog could result, causing delays in treatment of patients.

He further addresses the concerns of individuals and political representatives seeking to reverse or revise the current NRC guidelines on patient release after 131I therapy, stating that in spite of many epidemiologic studies completed on the issue, low-dose radiation has never been established to be a causal factor in the development of malignancy. "In no instance," he writes, "is an individual likely to receive radiation exposure in excess of a level deemed exceedingly safe."

The Society of Nuclear Medicine issued a joint statement with the American Thyroid Association, The Endocrine Society and the American Association of Clinical Endocrinologists explaining that based on existing scientific evidence, the current 131I regulations are safe for patients, their families and the public when radiation safety instructions are followed. However, SNM supports reexamination of this issue if new data emerge that support concerns about public safety.


Story Source:

The above story is based on materials provided by Society of Nuclear Medicine. Note: Materials may be edited for content and length.


Journal References:

  1. T. Higashi, R. Nishii, S. Yamada, Y. Nakamoto, K. Ishizu, S. Kawase, K. Togashi, S. Itasaka, M. Hiraoka, T. Misaki, J. Konishi. Delayed Initial Radioactive Iodine Therapy Resulted in Poor Survival in Patients with Metastatic Differentiated Thyroid Carcinoma: A Retrospective Statistical Analysis of 198 Cases. Journal of Nuclear Medicine, 2011; 52 (5): 683 DOI: 10.2967/jnumed.110.081059
  2. S. J. Goldsmith. The Real Cost of Theoretic Risk Avoidance: The Need to Challenge Unsubstantiated Concerns About 131I Therapy. Journal of Nuclear Medicine, 2011; 52 (5): 681 DOI: 10.2967/jnumed.110.081927

Cite This Page:

Society of Nuclear Medicine. "The case for maintaining current regulations on I-131 therapy." ScienceDaily. ScienceDaily, 5 May 2011. <www.sciencedaily.com/releases/2011/05/110505132119.htm>.
Society of Nuclear Medicine. (2011, May 5). The case for maintaining current regulations on I-131 therapy. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2011/05/110505132119.htm
Society of Nuclear Medicine. "The case for maintaining current regulations on I-131 therapy." ScienceDaily. www.sciencedaily.com/releases/2011/05/110505132119.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins